nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicloxacillin—SLCO1B1—Irinotecan—hematologic cancer	0.0652	0.112	CbGbCtD
Dicloxacillin—CYP3A4—Bexarotene—hematologic cancer	0.0399	0.0687	CbGbCtD
Dicloxacillin—CYP3A4—Lomustine—hematologic cancer	0.0371	0.0638	CbGbCtD
Dicloxacillin—CYP3A4—Busulfan—hematologic cancer	0.0371	0.0638	CbGbCtD
Dicloxacillin—SLCO1B1—Methotrexate—hematologic cancer	0.0345	0.0594	CbGbCtD
Dicloxacillin—CYP3A4—Thiotepa—hematologic cancer	0.0331	0.0569	CbGbCtD
Dicloxacillin—CYP3A4—Methoxsalen—hematologic cancer	0.0257	0.0442	CbGbCtD
Dicloxacillin—CYP3A4—Bortezomib—hematologic cancer	0.0244	0.0421	CbGbCtD
Dicloxacillin—CYP3A4—Daunorubicin—hematologic cancer	0.0234	0.0403	CbGbCtD
Dicloxacillin—CYP3A4—Cytarabine—hematologic cancer	0.0206	0.0355	CbGbCtD
Dicloxacillin—CYP3A4—Teniposide—hematologic cancer	0.0203	0.035	CbGbCtD
Dicloxacillin—CYP3A4—Ifosfamide—hematologic cancer	0.0188	0.0323	CbGbCtD
Dicloxacillin—CYP3A4—Imatinib—hematologic cancer	0.0179	0.0308	CbGbCtD
Dicloxacillin—CYP3A4—Ruxolitinib—hematologic cancer	0.0169	0.029	CbGbCtD
Dicloxacillin—CYP3A4—Nilotinib—hematologic cancer	0.0163	0.028	CbGbCtD
Dicloxacillin—CYP3A4—Vinorelbine—hematologic cancer	0.0161	0.0278	CbGbCtD
Dicloxacillin—CYP3A4—Triamcinolone—hematologic cancer	0.0148	0.0254	CbGbCtD
Dicloxacillin—CYP3A4—Dasatinib—hematologic cancer	0.0144	0.0248	CbGbCtD
Dicloxacillin—CYP3A4—Mitoxantrone—hematologic cancer	0.0142	0.0245	CbGbCtD
Dicloxacillin—CYP3A4—Betamethasone—hematologic cancer	0.0127	0.0218	CbGbCtD
Dicloxacillin—CYP3A4—Prednisolone—hematologic cancer	0.0125	0.0215	CbGbCtD
Dicloxacillin—CYP3A4—Prednisone—hematologic cancer	0.0118	0.0203	CbGbCtD
Dicloxacillin—CYP3A4—Irinotecan—hematologic cancer	0.0112	0.0193	CbGbCtD
Dicloxacillin—CYP3A4—Vinblastine—hematologic cancer	0.00995	0.0171	CbGbCtD
Dicloxacillin—CYP3A4—Vincristine—hematologic cancer	0.00978	0.0168	CbGbCtD
Dicloxacillin—CYP3A4—Etoposide—hematologic cancer	0.00896	0.0154	CbGbCtD
Dicloxacillin—CYP3A4—Dexamethasone—hematologic cancer	0.00737	0.0127	CbGbCtD
Dicloxacillin—CYP3A4—Doxorubicin—hematologic cancer	0.00611	0.0105	CbGbCtD
Dicloxacillin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000127	0.00911	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000124	0.00887	CbGpPWpGaD
Dicloxacillin—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000123	0.0088	CbGpPWpGaD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000115	0.00823	CbGpPWpGaD
Dicloxacillin—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.00011	0.00792	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.00011	0.00791	CbGpPWpGaD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000102	0.00734	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	9.92e-05	0.00712	CbGpPWpGaD
Dicloxacillin—Agranulocytosis—Methotrexate—hematologic cancer	9.57e-05	0.000236	CcSEcCtD
Dicloxacillin—Convulsion—Dexamethasone—hematologic cancer	9.54e-05	0.000235	CcSEcCtD
Dicloxacillin—Convulsion—Betamethasone—hematologic cancer	9.54e-05	0.000235	CcSEcCtD
Dicloxacillin—Diarrhoea—Ifosfamide—hematologic cancer	9.46e-05	0.000233	CcSEcCtD
Dicloxacillin—Pancytopenia—Doxorubicin—hematologic cancer	9.46e-05	0.000233	CcSEcCtD
Dicloxacillin—Nausea—Vinorelbine—hematologic cancer	9.45e-05	0.000233	CcSEcCtD
Dicloxacillin—Renal failure—Epirubicin—hematologic cancer	9.43e-05	0.000233	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Etoposide—hematologic cancer	9.43e-05	0.000233	CcSEcCtD
Dicloxacillin—Body temperature increased—Cisplatin—hematologic cancer	9.42e-05	0.000233	CcSEcCtD
Dicloxacillin—Myalgia—Dexamethasone—hematologic cancer	9.37e-05	0.000231	CcSEcCtD
Dicloxacillin—Myalgia—Betamethasone—hematologic cancer	9.37e-05	0.000231	CcSEcCtD
Dicloxacillin—Stomatitis—Epirubicin—hematologic cancer	9.35e-05	0.000231	CcSEcCtD
Dicloxacillin—Vomiting—Thalidomide—hematologic cancer	9.35e-05	0.000231	CcSEcCtD
Dicloxacillin—Pain—Etoposide—hematologic cancer	9.34e-05	0.00023	CcSEcCtD
Dicloxacillin—Neutropenia—Doxorubicin—hematologic cancer	9.31e-05	0.00023	CcSEcCtD
Dicloxacillin—Rash—Thalidomide—hematologic cancer	9.27e-05	0.000229	CcSEcCtD
Dicloxacillin—Discomfort—Dexamethasone—hematologic cancer	9.26e-05	0.000229	CcSEcCtD
Dicloxacillin—Discomfort—Betamethasone—hematologic cancer	9.26e-05	0.000229	CcSEcCtD
Dicloxacillin—Dermatitis—Thalidomide—hematologic cancer	9.26e-05	0.000229	CcSEcCtD
Dicloxacillin—Diarrhoea—Vincristine—hematologic cancer	9.22e-05	0.000228	CcSEcCtD
Dicloxacillin—Pain—Prednisolone—hematologic cancer	9.21e-05	0.000227	CcSEcCtD
Dicloxacillin—Haematuria—Epirubicin—hematologic cancer	9.15e-05	0.000226	CcSEcCtD
Dicloxacillin—Pruritus—Gemcitabine—hematologic cancer	9.05e-05	0.000223	CcSEcCtD
Dicloxacillin—Nausea—Thiotepa—hematologic cancer	9.03e-05	0.000223	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	9.02e-05	0.000223	CcSEcCtD
Dicloxacillin—Feeling abnormal—Etoposide—hematologic cancer	9e-05	0.000222	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Dexamethasone—hematologic cancer	8.99e-05	0.000222	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Betamethasone—hematologic cancer	8.99e-05	0.000222	CcSEcCtD
Dicloxacillin—Diarrhoea—Mitoxantrone—hematologic cancer	8.98e-05	0.000222	CcSEcCtD
Dicloxacillin—Diarrhoea—Irinotecan—hematologic cancer	8.98e-05	0.000222	CcSEcCtD
Dicloxacillin—Vomiting—Carmustine—hematologic cancer	8.98e-05	0.000222	CcSEcCtD
Dicloxacillin—Agranulocytosis—Epirubicin—hematologic cancer	8.96e-05	0.000221	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Etoposide—hematologic cancer	8.93e-05	0.00022	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	8.92e-05	0.0064	CbGpPWpGaD
Dicloxacillin—Rash—Carmustine—hematologic cancer	8.9e-05	0.00022	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Prednisone—hematologic cancer	8.9e-05	0.00022	CcSEcCtD
Dicloxacillin—Dermatitis—Carmustine—hematologic cancer	8.9e-05	0.00022	CcSEcCtD
Dicloxacillin—Vomiting—Alitretinoin—hematologic cancer	8.89e-05	0.00022	CcSEcCtD
Dicloxacillin—Feeling abnormal—Prednisolone—hematologic cancer	8.88e-05	0.000219	CcSEcCtD
Dicloxacillin—Anaemia—Prednisone—hematologic cancer	8.86e-05	0.000219	CcSEcCtD
Dicloxacillin—Shock—Betamethasone—hematologic cancer	8.84e-05	0.000218	CcSEcCtD
Dicloxacillin—Shock—Dexamethasone—hematologic cancer	8.84e-05	0.000218	CcSEcCtD
Dicloxacillin—Rash—Alitretinoin—hematologic cancer	8.82e-05	0.000218	CcSEcCtD
Dicloxacillin—Dermatitis—Alitretinoin—hematologic cancer	8.81e-05	0.000218	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Dexamethasone—hematologic cancer	8.8e-05	0.000217	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Betamethasone—hematologic cancer	8.8e-05	0.000217	CcSEcCtD
Dicloxacillin—Vomiting—Ifosfamide—hematologic cancer	8.79e-05	0.000217	CcSEcCtD
Dicloxacillin—Hypersensitivity—Cisplatin—hematologic cancer	8.78e-05	0.000217	CcSEcCtD
Dicloxacillin—Angioedema—Prednisone—hematologic cancer	8.76e-05	0.000216	CcSEcCtD
Dicloxacillin—Diarrhoea—Gemcitabine—hematologic cancer	8.75e-05	0.000216	CcSEcCtD
Dicloxacillin—Nausea—Thalidomide—hematologic cancer	8.73e-05	0.000216	CcSEcCtD
Dicloxacillin—Renal failure—Doxorubicin—hematologic cancer	8.73e-05	0.000215	CcSEcCtD
Dicloxacillin—Dyspepsia—Triamcinolone—hematologic cancer	8.72e-05	0.000215	CcSEcCtD
Dicloxacillin—Rash—Ifosfamide—hematologic cancer	8.72e-05	0.000215	CcSEcCtD
Dicloxacillin—Dermatitis—Ifosfamide—hematologic cancer	8.71e-05	0.000215	CcSEcCtD
Dicloxacillin—Urticaria—Etoposide—hematologic cancer	8.67e-05	0.000214	CcSEcCtD
Dicloxacillin—Stomatitis—Doxorubicin—hematologic cancer	8.66e-05	0.000214	CcSEcCtD
Dicloxacillin—Malaise—Prednisone—hematologic cancer	8.65e-05	0.000213	CcSEcCtD
Dicloxacillin—Abdominal pain—Etoposide—hematologic cancer	8.63e-05	0.000213	CcSEcCtD
Dicloxacillin—Body temperature increased—Etoposide—hematologic cancer	8.63e-05	0.000213	CcSEcCtD
Dicloxacillin—Vomiting—Vincristine—hematologic cancer	8.57e-05	0.000212	CcSEcCtD
Dicloxacillin—Urticaria—Prednisolone—hematologic cancer	8.56e-05	0.000211	CcSEcCtD
Dicloxacillin—Rash—Vincristine—hematologic cancer	8.5e-05	0.00021	CcSEcCtD
Dicloxacillin—Dermatitis—Vincristine—hematologic cancer	8.49e-05	0.00021	CcSEcCtD
Dicloxacillin—Pain—Triamcinolone—hematologic cancer	8.47e-05	0.000209	CcSEcCtD
Dicloxacillin—Haematuria—Doxorubicin—hematologic cancer	8.47e-05	0.000209	CcSEcCtD
Dicloxacillin—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	8.4e-05	0.00603	CbGpPWpGaD
Dicloxacillin—Hypotension—Dexamethasone—hematologic cancer	8.4e-05	0.000207	CcSEcCtD
Dicloxacillin—Hypotension—Betamethasone—hematologic cancer	8.4e-05	0.000207	CcSEcCtD
Dicloxacillin—Nausea—Carmustine—hematologic cancer	8.39e-05	0.000207	CcSEcCtD
Dicloxacillin—Angiopathy—Methotrexate—hematologic cancer	8.35e-05	0.000206	CcSEcCtD
Dicloxacillin—Vomiting—Irinotecan—hematologic cancer	8.35e-05	0.000206	CcSEcCtD
Dicloxacillin—Vomiting—Mitoxantrone—hematologic cancer	8.35e-05	0.000206	CcSEcCtD
Dicloxacillin—Nausea—Alitretinoin—hematologic cancer	8.31e-05	0.000205	CcSEcCtD
Dicloxacillin—Convulsion—Prednisone—hematologic cancer	8.31e-05	0.000205	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	8.29e-05	0.00595	CbGpPWpGaD
Dicloxacillin—Agranulocytosis—Doxorubicin—hematologic cancer	8.29e-05	0.000205	CcSEcCtD
Dicloxacillin—Rash—Irinotecan—hematologic cancer	8.28e-05	0.000204	CcSEcCtD
Dicloxacillin—Rash—Mitoxantrone—hematologic cancer	8.28e-05	0.000204	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	8.28e-05	0.00594	CbGpPWpGaD
Dicloxacillin—Dermatitis—Irinotecan—hematologic cancer	8.27e-05	0.000204	CcSEcCtD
Dicloxacillin—Dermatitis—Mitoxantrone—hematologic cancer	8.27e-05	0.000204	CcSEcCtD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	8.23e-05	0.00591	CbGpPWpGaD
Dicloxacillin—Nausea—Ifosfamide—hematologic cancer	8.21e-05	0.000203	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Betamethasone—hematologic cancer	8.19e-05	0.000202	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	8.19e-05	0.000202	CcSEcCtD
Dicloxacillin—Arthralgia—Prednisone—hematologic cancer	8.16e-05	0.000202	CcSEcCtD
Dicloxacillin—Myalgia—Prednisone—hematologic cancer	8.16e-05	0.000202	CcSEcCtD
Dicloxacillin—Feeling abnormal—Triamcinolone—hematologic cancer	8.16e-05	0.000201	CcSEcCtD
Dicloxacillin—Diarrhoea—Cisplatin—hematologic cancer	8.16e-05	0.000201	CcSEcCtD
Dicloxacillin—Vomiting—Gemcitabine—hematologic cancer	8.13e-05	0.000201	CcSEcCtD
Dicloxacillin—Discomfort—Prednisone—hematologic cancer	8.07e-05	0.000199	CcSEcCtD
Dicloxacillin—Rash—Gemcitabine—hematologic cancer	8.06e-05	0.000199	CcSEcCtD
Dicloxacillin—Dermatitis—Gemcitabine—hematologic cancer	8.06e-05	0.000199	CcSEcCtD
Dicloxacillin—Hypersensitivity—Etoposide—hematologic cancer	8.05e-05	0.000199	CcSEcCtD
Dicloxacillin—Nausea—Vincristine—hematologic cancer	8.01e-05	0.000198	CcSEcCtD
Dicloxacillin—Hypersensitivity—Prednisolone—hematologic cancer	7.93e-05	0.000196	CcSEcCtD
Dicloxacillin—Dyspepsia—Dexamethasone—hematologic cancer	7.91e-05	0.000195	CcSEcCtD
Dicloxacillin—Dyspepsia—Betamethasone—hematologic cancer	7.91e-05	0.000195	CcSEcCtD
Dicloxacillin—Urticaria—Triamcinolone—hematologic cancer	7.87e-05	0.000194	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	7.84e-05	0.00563	CbGpPWpGaD
Dicloxacillin—Body temperature increased—Triamcinolone—hematologic cancer	7.83e-05	0.000193	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Prednisone—hematologic cancer	7.83e-05	0.000193	CcSEcCtD
Dicloxacillin—Angiopathy—Epirubicin—hematologic cancer	7.82e-05	0.000193	CcSEcCtD
Dicloxacillin—Nausea—Irinotecan—hematologic cancer	7.8e-05	0.000192	CcSEcCtD
Dicloxacillin—Nausea—Mitoxantrone—hematologic cancer	7.8e-05	0.000192	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	7.76e-05	0.000192	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Betamethasone—hematologic cancer	7.76e-05	0.000192	CcSEcCtD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	7.75e-05	0.00556	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	7.74e-05	0.00555	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Bile acid and bile salt metabolism—ALB—hematologic cancer	7.73e-05	0.00555	CbGpPWpGaD
Dicloxacillin—Pruritus—Etoposide—hematologic cancer	7.73e-05	0.000191	CcSEcCtD
Dicloxacillin—Shock—Prednisone—hematologic cancer	7.7e-05	0.00019	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	7.69e-05	0.00552	CbGpPWpGaD
Dicloxacillin—Pain—Betamethasone—hematologic cancer	7.68e-05	0.00019	CcSEcCtD
Dicloxacillin—Pain—Dexamethasone—hematologic cancer	7.68e-05	0.00019	CcSEcCtD
Dicloxacillin—Nausea—Gemcitabine—hematologic cancer	7.6e-05	0.000187	CcSEcCtD
Dicloxacillin—Vomiting—Cisplatin—hematologic cancer	7.58e-05	0.000187	CcSEcCtD
Dicloxacillin—Rash—Cisplatin—hematologic cancer	7.52e-05	0.000186	CcSEcCtD
Dicloxacillin—Dermatitis—Cisplatin—hematologic cancer	7.51e-05	0.000185	CcSEcCtD
Dicloxacillin—Diarrhoea—Etoposide—hematologic cancer	7.47e-05	0.000184	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Methotrexate—hematologic cancer	7.44e-05	0.000184	CcSEcCtD
Dicloxacillin—Anaemia—Methotrexate—hematologic cancer	7.41e-05	0.000183	CcSEcCtD
Dicloxacillin—Feeling abnormal—Betamethasone—hematologic cancer	7.41e-05	0.000183	CcSEcCtD
Dicloxacillin—Feeling abnormal—Dexamethasone—hematologic cancer	7.41e-05	0.000183	CcSEcCtD
Dicloxacillin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—hematologic cancer	7.4e-05	0.00531	CbGpPWpGaD
Dicloxacillin—Flatulence—Epirubicin—hematologic cancer	7.39e-05	0.000182	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Betamethasone—hematologic cancer	7.35e-05	0.000181	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Dexamethasone—hematologic cancer	7.35e-05	0.000181	CcSEcCtD
Dicloxacillin—Hypersensitivity—Triamcinolone—hematologic cancer	7.3e-05	0.00018	CcSEcCtD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	7.29e-05	0.00523	CbGpPWpGaD
Dicloxacillin—Angiopathy—Doxorubicin—hematologic cancer	7.23e-05	0.000179	CcSEcCtD
Dicloxacillin—Malaise—Methotrexate—hematologic cancer	7.23e-05	0.000178	CcSEcCtD
Dicloxacillin—Leukopenia—Methotrexate—hematologic cancer	7.17e-05	0.000177	CcSEcCtD
Dicloxacillin—Urticaria—Dexamethasone—hematologic cancer	7.14e-05	0.000176	CcSEcCtD
Dicloxacillin—Urticaria—Betamethasone—hematologic cancer	7.14e-05	0.000176	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Prednisone—hematologic cancer	7.13e-05	0.000176	CcSEcCtD
Dicloxacillin—Abdominal pain—Betamethasone—hematologic cancer	7.1e-05	0.000175	CcSEcCtD
Dicloxacillin—Body temperature increased—Betamethasone—hematologic cancer	7.1e-05	0.000175	CcSEcCtD
Dicloxacillin—Body temperature increased—Dexamethasone—hematologic cancer	7.1e-05	0.000175	CcSEcCtD
Dicloxacillin—Abdominal pain—Dexamethasone—hematologic cancer	7.1e-05	0.000175	CcSEcCtD
Dicloxacillin—Nausea—Cisplatin—hematologic cancer	7.08e-05	0.000175	CcSEcCtD
Dicloxacillin—Pruritus—Triamcinolone—hematologic cancer	7.01e-05	0.000173	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Epirubicin—hematologic cancer	6.96e-05	0.000172	CcSEcCtD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	6.95e-05	0.00498	CbGpPWpGaD
Dicloxacillin—Convulsion—Methotrexate—hematologic cancer	6.94e-05	0.000171	CcSEcCtD
Dicloxacillin—Vomiting—Etoposide—hematologic cancer	6.94e-05	0.000171	CcSEcCtD
Dicloxacillin—Anaemia—Epirubicin—hematologic cancer	6.93e-05	0.000171	CcSEcCtD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	6.91e-05	0.00496	CbGpPWpGaD
Dicloxacillin—Dyspepsia—Prednisone—hematologic cancer	6.89e-05	0.00017	CcSEcCtD
Dicloxacillin—Rash—Etoposide—hematologic cancer	6.88e-05	0.00017	CcSEcCtD
Dicloxacillin—Dermatitis—Etoposide—hematologic cancer	6.88e-05	0.00017	CcSEcCtD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	6.88e-05	0.00493	CbGpPWpGaD
Dicloxacillin—Flatulence—Doxorubicin—hematologic cancer	6.84e-05	0.000169	CcSEcCtD
Dicloxacillin—Arthralgia—Methotrexate—hematologic cancer	6.82e-05	0.000168	CcSEcCtD
Dicloxacillin—Myalgia—Methotrexate—hematologic cancer	6.82e-05	0.000168	CcSEcCtD
Dicloxacillin—Rash—Prednisolone—hematologic cancer	6.79e-05	0.000168	CcSEcCtD
Dicloxacillin—Dermatitis—Prednisolone—hematologic cancer	6.78e-05	0.000167	CcSEcCtD
Dicloxacillin—Malaise—Epirubicin—hematologic cancer	6.76e-05	0.000167	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	6.76e-05	0.00485	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	6.76e-05	0.00485	CbGpPWpGaD
Dicloxacillin—Discomfort—Methotrexate—hematologic cancer	6.74e-05	0.000166	CcSEcCtD
Dicloxacillin—Leukopenia—Epirubicin—hematologic cancer	6.71e-05	0.000166	CcSEcCtD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	6.63e-05	0.00476	CbGpPWpGaD
Dicloxacillin—Confusional state—Methotrexate—hematologic cancer	6.59e-05	0.000163	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Methotrexate—hematologic cancer	6.54e-05	0.000161	CcSEcCtD
Dicloxacillin—Convulsion—Epirubicin—hematologic cancer	6.5e-05	0.00016	CcSEcCtD
Dicloxacillin—Nausea—Etoposide—hematologic cancer	6.49e-05	0.00016	CcSEcCtD
Dicloxacillin—Feeling abnormal—Prednisone—hematologic cancer	6.45e-05	0.000159	CcSEcCtD
Dicloxacillin—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	6.44e-05	0.00462	CbGpPWpGaD
Dicloxacillin—Ill-defined disorder—Doxorubicin—hematologic cancer	6.44e-05	0.000159	CcSEcCtD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	6.43e-05	0.00461	CbGpPWpGaD
Dicloxacillin—Anaemia—Doxorubicin—hematologic cancer	6.41e-05	0.000158	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Methotrexate—hematologic cancer	6.4e-05	0.000158	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Prednisone—hematologic cancer	6.4e-05	0.000158	CcSEcCtD
Dicloxacillin—Nausea—Prednisolone—hematologic cancer	6.4e-05	0.000158	CcSEcCtD
Dicloxacillin—Arthralgia—Epirubicin—hematologic cancer	6.39e-05	0.000158	CcSEcCtD
Dicloxacillin—Myalgia—Epirubicin—hematologic cancer	6.39e-05	0.000158	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	6.38e-05	0.00458	CbGpPWpGaD
Dicloxacillin—Pruritus—Dexamethasone—hematologic cancer	6.36e-05	0.000157	CcSEcCtD
Dicloxacillin—Pruritus—Betamethasone—hematologic cancer	6.36e-05	0.000157	CcSEcCtD
Dicloxacillin—Discomfort—Epirubicin—hematologic cancer	6.31e-05	0.000156	CcSEcCtD
Dicloxacillin—Vomiting—Triamcinolone—hematologic cancer	6.3e-05	0.000155	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	6.28e-05	0.00451	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	6.27e-05	0.0045	CbGpPWpGaD
Dicloxacillin—Malaise—Doxorubicin—hematologic cancer	6.26e-05	0.000154	CcSEcCtD
Dicloxacillin—Rash—Triamcinolone—hematologic cancer	6.24e-05	0.000154	CcSEcCtD
Dicloxacillin—Dermatitis—Triamcinolone—hematologic cancer	6.24e-05	0.000154	CcSEcCtD
Dicloxacillin—Urticaria—Prednisone—hematologic cancer	6.22e-05	0.000153	CcSEcCtD
Dicloxacillin—Leukopenia—Doxorubicin—hematologic cancer	6.21e-05	0.000153	CcSEcCtD
Dicloxacillin—Body temperature increased—Prednisone—hematologic cancer	6.19e-05	0.000153	CcSEcCtD
Dicloxacillin—Abdominal pain—Prednisone—hematologic cancer	6.19e-05	0.000153	CcSEcCtD
Dicloxacillin—Confusional state—Epirubicin—hematologic cancer	6.17e-05	0.000152	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	6.15e-05	0.00441	CbGpPWpGaD
Dicloxacillin—Diarrhoea—Dexamethasone—hematologic cancer	6.15e-05	0.000152	CcSEcCtD
Dicloxacillin—Diarrhoea—Betamethasone—hematologic cancer	6.15e-05	0.000152	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Epirubicin—hematologic cancer	6.12e-05	0.000151	CcSEcCtD
Dicloxacillin—Hypotension—Methotrexate—hematologic cancer	6.11e-05	0.000151	CcSEcCtD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	6.04e-05	0.00433	CbGpPWpGaD
Dicloxacillin—Shock—Epirubicin—hematologic cancer	6.02e-05	0.000149	CcSEcCtD
Dicloxacillin—Convulsion—Doxorubicin—hematologic cancer	6.01e-05	0.000148	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Epirubicin—hematologic cancer	5.99e-05	0.000148	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.96e-05	0.000147	CcSEcCtD
Dicloxacillin—Arthralgia—Doxorubicin—hematologic cancer	5.91e-05	0.000146	CcSEcCtD
Dicloxacillin—Myalgia—Doxorubicin—hematologic cancer	5.91e-05	0.000146	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	5.91e-05	0.00424	CbGpPWpGaD
Dicloxacillin—Nausea—Triamcinolone—hematologic cancer	5.88e-05	0.000145	CcSEcCtD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	5.88e-05	0.00422	CbGpPWpGaD
Dicloxacillin—Discomfort—Doxorubicin—hematologic cancer	5.84e-05	0.000144	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	5.83e-05	0.00418	CbGpPWpGaD
Dicloxacillin—Hypersensitivity—Prednisone—hematologic cancer	5.77e-05	0.000142	CcSEcCtD
Dicloxacillin—Dyspepsia—Methotrexate—hematologic cancer	5.76e-05	0.000142	CcSEcCtD
Dicloxacillin—Hypotension—Epirubicin—hematologic cancer	5.72e-05	0.000141	CcSEcCtD
Dicloxacillin—Vomiting—Betamethasone—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Dicloxacillin—Vomiting—Dexamethasone—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Dicloxacillin—Confusional state—Doxorubicin—hematologic cancer	5.71e-05	0.000141	CcSEcCtD
Dicloxacillin—Rash—Dexamethasone—hematologic cancer	5.67e-05	0.00014	CcSEcCtD
Dicloxacillin—Rash—Betamethasone—hematologic cancer	5.67e-05	0.00014	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Doxorubicin—hematologic cancer	5.66e-05	0.00014	CcSEcCtD
Dicloxacillin—Dermatitis—Betamethasone—hematologic cancer	5.66e-05	0.00014	CcSEcCtD
Dicloxacillin—Dermatitis—Dexamethasone—hematologic cancer	5.66e-05	0.00014	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.65e-05	0.000139	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	5.6e-05	0.00402	CbGpPWpGaD
Dicloxacillin—Pain—Methotrexate—hematologic cancer	5.59e-05	0.000138	CcSEcCtD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.59e-05	0.00401	CbGpPWpGaD
Dicloxacillin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	5.58e-05	0.000138	CcSEcCtD
Dicloxacillin—Shock—Doxorubicin—hematologic cancer	5.57e-05	0.000138	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Doxorubicin—hematologic cancer	5.55e-05	0.000137	CcSEcCtD
Dicloxacillin—Pruritus—Prednisone—hematologic cancer	5.54e-05	0.000137	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	5.48e-05	0.00393	CbGpPWpGaD
Dicloxacillin—Feeling abnormal—Methotrexate—hematologic cancer	5.39e-05	0.000133	CcSEcCtD
Dicloxacillin—Dyspepsia—Epirubicin—hematologic cancer	5.39e-05	0.000133	CcSEcCtD
Dicloxacillin—Diarrhoea—Prednisone—hematologic cancer	5.35e-05	0.000132	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Methotrexate—hematologic cancer	5.35e-05	0.000132	CcSEcCtD
Dicloxacillin—Nausea—Betamethasone—hematologic cancer	5.34e-05	0.000132	CcSEcCtD
Dicloxacillin—Nausea—Dexamethasone—hematologic cancer	5.34e-05	0.000132	CcSEcCtD
Dicloxacillin—Hypotension—Doxorubicin—hematologic cancer	5.29e-05	0.000131	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Epirubicin—hematologic cancer	5.28e-05	0.00013	CcSEcCtD
Dicloxacillin—Pain—Epirubicin—hematologic cancer	5.23e-05	0.000129	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	5.2e-05	0.00373	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	5.2e-05	0.00373	CbGpPWpGaD
Dicloxacillin—Urticaria—Methotrexate—hematologic cancer	5.2e-05	0.000128	CcSEcCtD
Dicloxacillin—Abdominal pain—Methotrexate—hematologic cancer	5.17e-05	0.000128	CcSEcCtD
Dicloxacillin—Body temperature increased—Methotrexate—hematologic cancer	5.17e-05	0.000128	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	5.16e-05	0.000127	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	5.12e-05	0.00368	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	5.12e-05	0.00368	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	5.12e-05	0.00368	CbGpPWpGaD
Dicloxacillin—Feeling abnormal—Epirubicin—hematologic cancer	5.04e-05	0.000125	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Epirubicin—hematologic cancer	5.01e-05	0.000124	CcSEcCtD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	4.99e-05	0.00358	CbGpPWpGaD
Dicloxacillin—Dyspepsia—Doxorubicin—hematologic cancer	4.99e-05	0.000123	CcSEcCtD
Dicloxacillin—Vomiting—Prednisone—hematologic cancer	4.98e-05	0.000123	CcSEcCtD
Dicloxacillin—Rash—Prednisone—hematologic cancer	4.93e-05	0.000122	CcSEcCtD
Dicloxacillin—Dermatitis—Prednisone—hematologic cancer	4.93e-05	0.000122	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.89e-05	0.000121	CcSEcCtD
Dicloxacillin—Urticaria—Epirubicin—hematologic cancer	4.86e-05	0.00012	CcSEcCtD
Dicloxacillin—Pain—Doxorubicin—hematologic cancer	4.84e-05	0.00012	CcSEcCtD
Dicloxacillin—Body temperature increased—Epirubicin—hematologic cancer	4.84e-05	0.000119	CcSEcCtD
Dicloxacillin—Abdominal pain—Epirubicin—hematologic cancer	4.84e-05	0.000119	CcSEcCtD
Dicloxacillin—Hypersensitivity—Methotrexate—hematologic cancer	4.82e-05	0.000119	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	4.75e-05	0.00341	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	4.75e-05	0.00341	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	4.75e-05	0.00341	CbGpPWpGaD
Dicloxacillin—Feeling abnormal—Doxorubicin—hematologic cancer	4.67e-05	0.000115	CcSEcCtD
Dicloxacillin—Nausea—Prednisone—hematologic cancer	4.65e-05	0.000115	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.63e-05	0.000114	CcSEcCtD
Dicloxacillin—Pruritus—Methotrexate—hematologic cancer	4.63e-05	0.000114	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	4.61e-05	0.00331	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4.57e-05	0.00328	CbGpPWpGaD
Dicloxacillin—Hypersensitivity—Epirubicin—hematologic cancer	4.51e-05	0.000111	CcSEcCtD
Dicloxacillin—Urticaria—Doxorubicin—hematologic cancer	4.5e-05	0.000111	CcSEcCtD
Dicloxacillin—Abdominal pain—Doxorubicin—hematologic cancer	4.48e-05	0.000111	CcSEcCtD
Dicloxacillin—Body temperature increased—Doxorubicin—hematologic cancer	4.48e-05	0.000111	CcSEcCtD
Dicloxacillin—Diarrhoea—Methotrexate—hematologic cancer	4.48e-05	0.00011	CcSEcCtD
Dicloxacillin—Pruritus—Epirubicin—hematologic cancer	4.33e-05	0.000107	CcSEcCtD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	4.31e-05	0.00309	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	4.28e-05	0.00307	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.24e-05	0.00304	CbGpPWpGaD
Dicloxacillin—Diarrhoea—Epirubicin—hematologic cancer	4.19e-05	0.000103	CcSEcCtD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	4.19e-05	0.003	CbGpPWpGaD
Dicloxacillin—Hypersensitivity—Doxorubicin—hematologic cancer	4.17e-05	0.000103	CcSEcCtD
Dicloxacillin—Vomiting—Methotrexate—hematologic cancer	4.16e-05	0.000103	CcSEcCtD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	4.16e-05	0.00298	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	4.14e-05	0.00297	CbGpPWpGaD
Dicloxacillin—Rash—Methotrexate—hematologic cancer	4.12e-05	0.000102	CcSEcCtD
Dicloxacillin—Dermatitis—Methotrexate—hematologic cancer	4.12e-05	0.000102	CcSEcCtD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.05e-05	0.00291	CbGpPWpGaD
Dicloxacillin—Pruritus—Doxorubicin—hematologic cancer	4.01e-05	9.89e-05	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	3.99e-05	0.00286	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	3.96e-05	0.00284	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.94e-05	0.00283	CbGpPWpGaD
Dicloxacillin—Vomiting—Epirubicin—hematologic cancer	3.89e-05	9.61e-05	CcSEcCtD
Dicloxacillin—Nausea—Methotrexate—hematologic cancer	3.89e-05	9.59e-05	CcSEcCtD
Dicloxacillin—Diarrhoea—Doxorubicin—hematologic cancer	3.88e-05	9.56e-05	CcSEcCtD
Dicloxacillin—Rash—Epirubicin—hematologic cancer	3.86e-05	9.53e-05	CcSEcCtD
Dicloxacillin—Dermatitis—Epirubicin—hematologic cancer	3.86e-05	9.52e-05	CcSEcCtD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	3.76e-05	0.0027	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	3.7e-05	0.00266	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.7e-05	0.00266	CbGpPWpGaD
Dicloxacillin—Nausea—Epirubicin—hematologic cancer	3.64e-05	8.97e-05	CcSEcCtD
Dicloxacillin—Vomiting—Doxorubicin—hematologic cancer	3.6e-05	8.89e-05	CcSEcCtD
Dicloxacillin—Rash—Doxorubicin—hematologic cancer	3.57e-05	8.81e-05	CcSEcCtD
Dicloxacillin—Dermatitis—Doxorubicin—hematologic cancer	3.57e-05	8.81e-05	CcSEcCtD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.51e-05	0.00252	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.49e-05	0.00251	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	3.44e-05	0.00247	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.39e-05	0.00243	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	3.38e-05	0.00242	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.37e-05	0.00242	CbGpPWpGaD
Dicloxacillin—Nausea—Doxorubicin—hematologic cancer	3.36e-05	8.3e-05	CcSEcCtD
Dicloxacillin—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	3.33e-05	0.00239	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.3e-05	0.00237	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	3.28e-05	0.00235	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.24e-05	0.00233	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.21e-05	0.0023	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.21e-05	0.0023	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.21e-05	0.0023	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.15e-05	0.00226	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.13e-05	0.00224	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.06e-05	0.0022	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.95e-05	0.00212	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.94e-05	0.00211	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.89e-05	0.00207	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PHYH—hematologic cancer	2.86e-05	0.00205	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GMPS—hematologic cancer	2.86e-05	0.00205	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—FTCD—hematologic cancer	2.86e-05	0.00205	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.83e-05	0.00203	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.73e-05	0.00196	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.7e-05	0.00194	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.67e-05	0.00191	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SMPD3—hematologic cancer	2.62e-05	0.00188	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.61e-05	0.00187	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.54e-05	0.00182	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.54e-05	0.00182	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.47e-05	0.00177	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.44e-05	0.00175	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.38e-05	0.00171	CbGpPWpGaD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.35e-05	0.00169	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.32e-05	0.00167	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.29e-05	0.00164	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—B3GAT1—hematologic cancer	2.29e-05	0.00164	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—DCK—hematologic cancer	2.29e-05	0.00164	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ASNS—hematologic cancer	2.29e-05	0.00164	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.24e-05	0.0016	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.19e-05	0.00157	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HDC—hematologic cancer	2.17e-05	0.00156	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.14e-05	0.00154	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.13e-05	0.00153	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.11e-05	0.00152	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.11e-05	0.00152	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.07e-05	0.00148	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.06e-05	0.00148	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.02e-05	0.00145	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2.02e-05	0.00145	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.99e-05	0.00143	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CDA—hematologic cancer	1.98e-05	0.00142	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.91e-05	0.00137	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PC—hematologic cancer	1.91e-05	0.00137	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SLC35B2—hematologic cancer	1.84e-05	0.00132	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GBA—hematologic cancer	1.84e-05	0.00132	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.84e-05	0.00132	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.78e-05	0.00128	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.75e-05	0.00125	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—MTAP—hematologic cancer	1.69e-05	0.00121	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.66e-05	0.00119	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.59e-05	0.00114	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.55e-05	0.00111	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—FHL2—hematologic cancer	1.5e-05	0.00108	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—AGRN—hematologic cancer	1.47e-05	0.00106	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HMMR—hematologic cancer	1.4e-05	0.001	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—IDH2—hematologic cancer	1.4e-05	0.001	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.38e-05	0.000988	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.32e-05	0.000946	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ARNTL—hematologic cancer	1.31e-05	0.000943	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.29e-05	0.000926	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.29e-05	0.000925	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CA9—hematologic cancer	1.28e-05	0.000917	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ACP5—hematologic cancer	1.28e-05	0.000917	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.28e-05	0.000917	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NCOR2—hematologic cancer	1.26e-05	0.000905	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—IDH1—hematologic cancer	1.2e-05	0.000862	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.2e-05	0.000858	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000853	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000853	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—TXN—hematologic cancer	1.19e-05	0.000853	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000835	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.15e-05	0.000827	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.14e-05	0.000815	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000802	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.00078	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.00078	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.00076	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.06e-05	0.00076	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.04e-05	0.000749	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000736	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ADCY7—hematologic cancer	9.96e-06	0.000715	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NCOA3—hematologic cancer	9.96e-06	0.000715	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NUP214—hematologic cancer	9.89e-06	0.00071	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.79e-06	0.000702	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—MTR—hematologic cancer	9.69e-06	0.000695	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ABCG2—hematologic cancer	9.69e-06	0.000695	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ENO2—hematologic cancer	9.5e-06	0.000682	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTT1—hematologic cancer	9.22e-06	0.000661	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.07e-06	0.000651	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—SDC1—hematologic cancer	9.01e-06	0.000646	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GMPS—hematologic cancer	8.83e-06	0.000633	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—FTCD—hematologic cancer	8.83e-06	0.000633	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PHYH—hematologic cancer	8.83e-06	0.000633	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.63e-06	0.000619	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.6e-06	0.000617	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.49e-06	0.000609	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.12e-06	0.000583	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.08e-06	0.000579	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SMPD3—hematologic cancer	8.07e-06	0.000579	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CD44—hematologic cancer	7.66e-06	0.00055	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NQO1—hematologic cancer	7.66e-06	0.00055	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.5e-06	0.000538	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYCS—hematologic cancer	7.25e-06	0.00052	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	7.2e-06	0.000517	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ASNS—hematologic cancer	7.06e-06	0.000506	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—DCK—hematologic cancer	7.06e-06	0.000506	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.06e-06	0.000506	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HDC—hematologic cancer	6.69e-06	0.00048	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.48e-06	0.000465	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTP1—hematologic cancer	6.39e-06	0.000458	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.18e-06	0.000443	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CDA—hematologic cancer	6.12e-06	0.000439	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ABCB1—hematologic cancer	6.05e-06	0.000434	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PC—hematologic cancer	5.89e-06	0.000423	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NCOR1—hematologic cancer	5.87e-06	0.000421	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTM1—hematologic cancer	5.87e-06	0.000421	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GBA—hematologic cancer	5.69e-06	0.000408	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.69e-06	0.000408	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—MTAP—hematologic cancer	5.2e-06	0.000373	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—MTHFR—hematologic cancer	5.19e-06	0.000372	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—FHL2—hematologic cancer	4.64e-06	0.000333	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.57e-06	0.000328	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—AGRN—hematologic cancer	4.55e-06	0.000326	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	4.36e-06	0.000313	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—IDH2—hematologic cancer	4.31e-06	0.000309	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HMMR—hematologic cancer	4.31e-06	0.000309	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.05e-06	0.000291	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CREBBP—hematologic cancer	4.04e-06	0.00029	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CA9—hematologic cancer	3.94e-06	0.000283	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ACP5—hematologic cancer	3.94e-06	0.000283	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.89e-06	0.000279	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	3.83e-06	0.000275	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALB—hematologic cancer	3.78e-06	0.000271	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.71e-06	0.000266	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.67e-06	0.000263	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—TXN—hematologic cancer	3.67e-06	0.000263	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.67e-06	0.000263	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	3.62e-06	0.00026	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.59e-06	0.000257	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.45e-06	0.000247	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.35e-06	0.000241	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.35e-06	0.000241	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.34e-06	0.00024	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.27e-06	0.000234	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.16e-06	0.000227	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.07e-06	0.00022	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.07e-06	0.00022	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.05e-06	0.000219	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.99e-06	0.000214	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—MTR—hematologic cancer	2.99e-06	0.000214	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ENO2—hematologic cancer	2.93e-06	0.00021	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PTEN—hematologic cancer	2.89e-06	0.000207	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.84e-06	0.000204	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.78e-06	0.000199	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—EP300—hematologic cancer	2.75e-06	0.000197	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CD44—hematologic cancer	2.36e-06	0.000169	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.36e-06	0.000169	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.24e-06	0.00016	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.22e-06	0.000159	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.04e-06	0.000146	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.97e-06	0.000141	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.86e-06	0.000134	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.81e-06	0.00013	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.81e-06	0.00013	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.66e-06	0.000119	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.6e-06	0.000115	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.34e-06	9.65e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.25e-06	8.94e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.18e-06	8.48e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALB—hematologic cancer	1.17e-06	8.37e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.12e-06	8.01e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.03e-06	7.39e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PTEN—hematologic cancer	8.9e-07	6.39e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—EP300—hematologic cancer	8.49e-07	6.09e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.28e-07	4.51e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—AKT1—hematologic cancer	5.13e-07	3.68e-05	CbGpPWpGaD
